Publications by authors named "Lisa Nottebaum"

Claim this Profile
D
Design and Synthesis of γ- and δ-Lactam M Positive Allosteric Modulators (PAMs): Convulsion and Cholinergic Toxicity of an M-Selective PAM with Weak Agonist Activity.
Jennifer E Davoren, Michelle Garnsey, Betty Pettersen, Michael A Brodney, Jeremy R Edgerton, Lisa Nottebaum

J Med Chem· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects.
Jennifer E Davoren, Che-Wah Lee, Michelle Garnsey, Michael A Brodney, Jason Cordes, Lisa Nottebaum

J Med Chem· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies.
Bhavatarini Vangamudi, Thomas A Paul, Parantu K Shah, Maria Kost-Alimova, Lisa Nottebaum

Cancer Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Manipulation of small-molecule inhibitory kinetics modulates MCH-R1 function.
David A Schwarz, Molly M Allen, Robert E Petroski, Jordan E Pomeroy, Christopher E Heise, Lisa M Nottebaum

Mol Cell Endocrinol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel cell-based assay for G-protein-coupled receptor-mediated cyclic adenosine monophosphate response element binding protein phosphorylation.
Julie V Selkirk, Lisa M Nottebaum, Ian C Ford, Mark Santos, Siobhan Malany

J Biomol Screen· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the GLT-1 subtype of glutamate transporter in glutamate homeostasis: the GLT-1-preferring inhibitor WAY-855 produces marginal neurotoxicity in the rat hippocampus.
Julie V Selkirk, Lisa M Nottebaum, Alicia M Vana, Gail M Verge, Kenneth B Mackay

Eur J Neurosci· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis